ValueAct Capital Management, L.P.
CIK 1351069 · last filed 2023-05-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MSI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BUILDING D, 4TH FLOOR
SAN FRANCISCO, CA 94129
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Altus Power, Inc. (AMPS) Delisted | Director | 4,017,628 | $4.99 | $20.05M | $0 | 1 | 2023-05-02 |
| NSIT | Director | 3,494,041 | $159.74 | $558.14M | $8.95M | 1 | 2022-02-28 |
| HE | Director | 2,015,493 | $8.44 | $17.01M | $0 | 1 | 2020-07-02 |
| CBRE | Director | 10,236,837 | $136.69 | $1.40B | $0 | 1 | 2020-05-18 |
| TRN | 10%+ Owner | 25,893,819 | $29.79 | $771.38M | $15.43M | 5 | 2020-02-11 |
| STX | Director | 4,262,493 | $465.48 | $1.98B | $66.17M | 3 | 2019-10-30 |
| BHC | Director | 1,069,678 | $8.18 | $8.74M | $0 | 1 | 2019-05-03 |
| WILLIS TOWERS WATSON PLC (WLTW) Delisted | Director | 5,295,418 | $231.56 | $1.23B | -$170.28M | 3 | 2017-08-16 |
| MSFT | Director | 1,567,759 | $532.36 | $834.61M | $0 | 2 | 2017-05-31 |
| CBRE GROUP, INC. (CBG) Delisted | Director | 41,623,250 | — | — | $89.55M | 2 | 2016-11-09 |
| MSCI | Director | 3,889,900 | $637.97 | $2.48B | -$146.11M | 2 | 2016-05-04 |
| MSI | Director | 16,964,933 | $515.65 | $8.75B | -$466.34M | 2 | 2016-03-02 |
| ALSN | Director | 19,125,204 | $116.21 | $2.22B | $0 | 2 | 2015-11-30 |
| ADBE | Director | 23,890,116 | $239.44 | $5.72B | -$50.52M | 1 | 2014-07-31 |
| IT | Director | 3,074,702 | $187.10 | $575.28M | -$21.77M | 2 | 2011-11-30 |
| IMMUCOR INC (BLUD) Delisted | 10%+ Owner | 7,140,665 | — | — | $5.98M | 1 | 2010-05-24 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | 10%+ Owner | 17,028,093 | — | — | $1.27M | 2 | 2009-06-26 |
| LiveRamp Holdings, Inc. (ACXM) Delisted | 10%+ Owner | 10,333,857 | — | — | $0 | 1 | 2008-08-28 |
| SIRVA INC (SIR) Delisted | Director | 8,567,763 | — | — | $0 | 1 | 2007-08-27 |
| Archrock, Inc. (EXH) Delisted | Director | 562,315 | — | — | $0 | 1 | 2007-08-22 |
Recent Filings · Page 4 of 5
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-07 | — | Buy (P) | +152,807 | $7.30M | |
| 2012-05-10 | — | Buy (P) | +419,000 | $21.37M | |
| 2011-11-30 | IT | Sell (S) | −579,300 | -$21.77M | EDGAR |
| 2011-05-17 | — | Sell (S) | −4,498,180 | -$224.86M | |
| 2011-04-05 | IT | Grant (A) | — | $0 | EDGAR |
| 2010-05-24 | IMMUCOR INC (BLUD) Delisted | Buy (P) | +300,000 | $5.98M | EDGAR |
| 2009-06-26 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +51,600 | $1.27M | EDGAR |
| 2009-03-02 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Other (J) | — | $0 | EDGAR |
| 2008-08-28 | LiveRamp Holdings, Inc. (ACXM) Delisted | Grant (A) | +8,262 | $115.0K | EDGAR |
| 2007-08-27 | SIRVA INC (SIR) Delisted | Other (J) | +1,435,863 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.